Skip to main content

Sony Acquires Microfluidic POC Firm Micronics

NEW YORK (GenomeWeb News) – Sony today announced it has acquired microfluidics-based diagnostic tools firm Micronics for an undisclosed amount.

The deal was done through Sony's wholly-owned US subsidiary Sony Corporation of America and is expected to accelerate Sony's own R&D work in the point-of-care space and to hasten commercialization of Micronics' products.

Founded in 1996, Micronics develops near-patient in vitro products for disease diagnosis, prognosis, and treatment monitoring. Last year, it received a $2.6 million grant from the US Department of Defense for the development of its PanNAT system for point-of-care molecular diagnostic testing of infectious pathogens.

Micronics will remain headquartered in Redmond, Wash., where it will operate as a wholly-owned subsidiary of Sony Corporation of America. Its current management, including President Karen Hedine, will remain with the firm.

"[W]e at Micronics aim to make full use of Sony's superior consumer-based technologies, product development capabilities and capacity to distribute products globally in the development of Micronics' products," Hedine said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.